Advertisement

Topics

Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Schizophrenia,Bipolar Disorder, Date of authorisation: 12/12/2007, Revision: 24, Status: Authorised

05:30 EDT 14 Jun 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Schizophrenia,Bipolar Disorder, Date of authorisation: 12/12/2007, Revision: 24, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Schizophrenia,Bipolar Disorder, Date of authorisation: 12/12/2007, Revision: 24, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Schizophrenia,Bipolar Disorder, Date of authorisation: 12/12/2007, Revision: 24, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...